Skip to content
Wednesday, August 10, 2022
  • Staff Email
  • FAQs
  • facebook
  • twitter
MCAZ

MCAZ

Protecting your right to human medicines and medical devices
MCAZ
MENUMENU
MENUMENU
  • Home
  • About Us
        • Who We Are
        • MCAZ Board Members
        • Corporate Governance
        • Tenders
        • Careers @ MCAZ
        • Privacy Policy
        • Client Service Charter
        • Board Charter
  • Regulatory Functions
        • Evaluation and Registration
          • Overview
          • Find A Registered Medicine
          • How to Register
          • Alternative Submission Pathways
          • Registered & Approved Medicines
          • Human Medicines Guidelines
          • Key timelines for the Evaluation and Registration
          • Important Information
          • Summary for Product Characteristics
        • Licensing and Enforcement
          • Overview
          • Licensing
          • Inspections
          • Import & Export
          • Product Defects & Recalls
          • Enquiries
        • Pharmacoviligance and Clinical Trials
          • Current Projects
          • Pharmacovigilance Centre
          • Publications
          • Clinical Trials
          • WHO Pharmacovigilance Toolkit
        • Laboratory Services
          • Medical Devices and Microbiology
          • Chemistry
        • Legal and Coperate Affairs
          • Overview
          • Legislation
            • Principal legislation
        • Procurement Section
          • Tenders
          • Request For Quotations
  • Online Services
        • Online Registers
        • ADR E-Reporting
          • Consumer Reporting
          • Healthcare Professional Reporting
        • Import/Export for Registered Medicines
        • e-Clinical Trials
        • Online Persons and Premises Renewals
        • Section 75 Authorisation
  • Publications
    • Annual Reports
    • Press Release
  • Vaccine Safety
  • Downloads
  • RCore Trainings
  • Contact Us

Download Category: SMPCs

Imatinib (as mesilate) 100mg tablets_5084_SmPC

Imatinib (as mesilate) 100mg tablets_5084_SmPC14 DownloadsDownload Now!

View More Imatinib (as mesilate) 100mg tablets_5084_SmPC

Esomeprazole magnesium 40 mg gastro-resistant tablets_4350_SmPC

Esomeprazole magnesium 40 mg gastro-resistant tablets_4350_SmPC15 DownloadsDownload Now!

View More Esomeprazole magnesium 40 mg gastro-resistant tablets_4350_SmPC

Esomeprazole magnesium 20 mg gastro-resistant tablets_4349_SmPC

Esomeprazole magnesium 20 mg gastro-resistant tablets_4349_SmPC14 DownloadsDownload Now!

View More Esomeprazole magnesium 20 mg gastro-resistant tablets_4349_SmPC

Esomeprazole (as sodium) 40 mg Powder for solution for injection or infusion_5167_SmPC

Esomeprazole (as sodium) 40 mg Powder for solution for injection or infusion_5167_SmPC13 DownloadsDownload Now!

View More Esomeprazole (as sodium) 40 mg Powder for solution for injection or infusion_5167_SmPC

Diclofenac (as sodium) 75mg per 3ml solution for injection_1207_SmPC

Diclofenac (as sodium) 75mg per 3ml solution for injection_1207_SmPC13 DownloadsDownload Now!

View More Diclofenac (as sodium) 75mg per 3ml solution for injection_1207_SmPC

Diclofenac (as sodium) 50mg Suppositories_0884_SmPC

Diclofenac (as sodium) 50mg Suppositories_0884_SmPC10 DownloadsDownload Now!

View More Diclofenac (as sodium) 50mg Suppositories_0884_SmPC

Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU opthalmic ointment_3322_SmPC

Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU opthalmic ointment_3322_SmPC16 DownloadsDownload Now!

View More Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU opthalmic ointment_3322_SmPC

Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU eye drops suspension_3365_SmPC

Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU eye drops suspension_3365_SmPC14 DownloadsDownload Now!

View More Dexamethasone_polymyxin B sulphate_ neomycin sulphate (as base) 1mg_ 6000 IU_3500 IU eye drops suspension_3365_SmPC

Dexamethasone 0.1% wIv eye drops suspension_3364_SmPC

Dexamethasone 0.1% wIv eye drops suspension_3364_SmPC17 DownloadsDownload Now!

View More Dexamethasone 0.1% wIv eye drops suspension_3364_SmPC

Darunavir 600mg tablets_4801_SmPC

Darunavir 600mg tablets_4801_SmPC12 DownloadsDownload Now!

View More Darunavir 600mg tablets_4801_SmPC

Posts navigation

Page 1 Page 2 … Page 5 Next page

Recent Posts

Previous Next
  • 2021 Customer Complaints Trend Analysis Report
    2021 Customer Complaints Trend Analysis Report
    2021 Customer Complaints Trend...
    Read more
  • 2020 Customer Complaints Trend Analysis
    2020 Customer Complaints Trend Analysis
    2020 Customer Complaints Trend...
    Read more
  • ZIMBABWE LIST OF COVID-19 EMERGENCY USE AUTHORISATIONS
    ZIMBABWE LIST OF COVID-19 EMERGENCY USE AUTHORISATIONS
    ZIMBABWE LIST OF COVID-19 EMER...
    Read more
  • Veterinary Medicines Zazibona
    Veterinary Medicines Zazibona
    The Veterinary Medicines Zazib...
    Read more
  • MCAZ Code of Ethics
    MCAZ Code of Ethics
    In pursuit of promoting high e...
    Read more
  • MCAZ Tender Advert 01042022
    MCAZ Tender Advert 01042022
    INVITATION TO COMPETITIVE BIDD...
    Read more
  • MCAZ Reliance Policy
    MCAZ Reliance Policy
    The Medicines Control Authorit...
    Read more
  • Quality Policy Statement
    Quality Policy Statement
    The Quality Policy of the Medi...
    Read more
  • 2019 Customer Complaints Trends Analysis
    2019 Customer Complaints Trends Analysis
    In order to improve service de...
    Read more
More from Latest News

Get E-PV Mobile Applications

Related Links

  • Staff Email
  • FAQs

MCAZ Facebook

Medicines Control Authority of Zimbabwe

1 week ago

Medicines Control Authority of Zimbabwe
Medicines are very useful but can cause side effects in some patients. Seek medical help as soon as you experience any side effects and also report to the regulatory authority on e-pv.mcaz.co.zw #medicinessafety ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Medicines Control Authority of Zimbabwe

1 week ago

Medicines Control Authority of Zimbabwe
Meet Mr. Albert Maqolo , Senior Analyst of Microbiology and Medical Devices Unit at Medicines Control Authority of Zimbabwe, who will be a speaker at PharmaReg AfriSummit's Pharmacovigilance Training 2022! He has more than 10 years of experience in the regulation of medical devices. He specialises in regulation and quality conformity assessments of medical devices and in-vitro diagnostics. He is an experienced ISO 13485 factory auditor and ISO 17025 Quality Management System (QMS) auditor. He is also a member of the ISO/TC 157 technical committee (Non-systemic contraceptives and STI barrier prophylactics). Albert has played a key role in ensuring that the public has access to quality, safe and effective medical devices through development and continuous improvement of regulatory processes. Visit our website to read more about Mr. Albert, and don’t forget to register and attend PharmaReg AfriSummit 2022:lnkd.in/eYd4ZPy#PharmaRegAfriSummit #Africa #pharmacovigilance #pharma #pharmaceuticals #pharmaceutical #regulatoryaffairs #zimbabwe #pharmaceuticalindustry ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

MCAZ Twitter

Our Address

  • 106 Baines Ave, Harare, Zimbabwe
  • +263-242-736981/5;
    708255; 792165;
  • 0772-145-191/2/3
  • mcaz@mcaz.co.zw
MCAZ | Copyright © 2021 Medicines Control Authority of Zimbabwe. All Rights Reserved.